12
Feb
2020
Immunicum Article in BioStock
Immunicum was recently covered in BioStock’s article, “Immunicum presenterade positiva fas II-data från MERECA” For access to the… Read more
News
12
Feb
2020
RedEye Interview with COO, Sijme Zeilemaker
RedEye interviewed Immunicum’s COO, Sijme Zeilemaker following the presentation of the updated MERECA results at ASCO-SITC: RedEye Interview
7
Feb
2020
Edison Coverage from 7 February 2020
Edison report: https://www.edisongroup.com/publication/updated-phase-ii-mereca-data-positive/26121 EdisonTV interview: https://www.edisongroup.com/edison-tv/executive-interview-immunicum-2/
6
Feb
2020
Phase II MERECA Updated Results Video
Immunicum’s Interim CEO, Alex Karlsson-Parra provides background & insights on the updated Phase II MERECA results in this… Read more
6
Feb
2020
Corporate Presentation – February 2020
Click here to view our most recent corporate presentation: February 2020
6
Feb
2020
ASCO-SITC MERECA Podium Presentation
A randomized phase II study with ilixadencel, a cell-based immune primer, plus sunitinib versus sunitinib alone in synchronous… Read more
6
Feb
2020
ASCO-SITC GIST Poster now available under publications
Immunicum/technology/publications
5
Feb
2020
BioStock Interview with COO Sijme Zeilemaker
Immunicum COO, Sijme Zeilemaker, was interviewed by BioStock. Sijme answered questions about the current landscape and upcoming updates… Read more
13
Dec
2019
Immunicum Article in BioStock
Immunicum was recently covered in BioStock’s article, “Immunicum kommenterar vd-bytet” Please note, the article is only available in… Read more
13
Dec
2019
RedEye Interview with Michael Oredsson, Chairman of the Board
Chairman of the Board, Michael Oredsson, was interviewed by RedEye this morning in regards to the change… Read more
